top of page
Commercial Buildings_edited.jpg

Pharmacoepidemiology solutions for a safer world

​

​

Find out more about epifocus by clicking on the button below.

​​

about us.

epifocus provides scientific consulting in pharmacoepidemiology. Our dedicated team supports pharmaceutical and biotechnology companies to find solutions in real-world evidence generation across the product lifecycle. With sustainability and high standards at the heart of our ethos, we use the best methods available to provide meaningful and unbiased insights to support your decision-making.

 

Founded in 2017, we are based in London and Madrid.

Home: Service

what we do.

epifocus carry out evidence reviews (targeted or systematic), database studies (from primary or secondary data sources), data management, and statistical analyses. We also provide consultancy in study design and execution as well as evidence-generation strategy. 

​

Find out more by clicking on the button below.

​​

Home: Homepage_about
Home: Widget

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)

Deslee G, Fabry-Vendrand C, Poccardi N, Thabut G, Eteve Pitsaer C, Coriat A, Renaudat C, Maguire A, Pinto T. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study). BMJ Open Respir Res. 2023 Jun;10(1):e001585. doi: 10.1136/bmjresp-2022-001585. PMID: 37263738; PMCID: PMC10255131.

see all of our publications.

Above is just a selection of our newer publications. 

Click the button below to see the full list of our publications.

thanks for visiting our new website.

You are currently using epifocus' new website. 

We hope you like it.

If you encounter any issues, please fill in the bug report form by clicking here.

bottom of page